Company / Tangible Book Value per Share
NewAmsterdam Pharma Co N.V. Tangible Book Value per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$5.77
FY2025
5-year range
-$10.37 / $22.68
FY2021-FY2025
Trend
-28.1%
vs FY2024
Sector context
#88 of 207
Health Care
What the data says
At $5.77, NewAmsterdam Pharma Co N.V.'s tangible book value per share ranks #88 of 207 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 5 years, ranging from $-10.37 in FY2021 to $22.68 in FY2022.
Based on SEC 10-K filings.
5.77 in FY2025 with a 3-year CAGR of -36.6%.
Improved from $3.51 to $5.77 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -36.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-94.8% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 28.1% year-over-year.
- Ranks #88 out of 207 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
- Lowest tangible book value per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.77 | -28.1% |
| FY2024 | $8.03 | +128.7% |
| FY2023 | $3.51 | -84.5% |
| FY2022 | $22.68 | +318.7% |
| FY2021 | -$10.37 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026